These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33982796)

  • 61. Atrial fibrillation diagnosed after stroke and dementia risk: cohort study of first-ever ischaemic stroke patients aged 65 or older.
    Krawczyk M; Fridman S; Cheng Y; Fang J; Saposnik G; Sposato LA
    Europace; 2019 Dec; 21(12):1793-1801. PubMed ID: 31531673
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Systemic embolism in amyloid transthyretin cardiomyopathy.
    Vilches S; Fontana M; Gonzalez-Lopez E; Mitrani L; Saturi G; Renju M; Griffin JM; Caponetti A; Gnanasampanthan S; De Los Santos J; Gagliardi C; Rivas A; Dominguez F; Longhi S; Rapezzi C; Maurer MS; Gillmore J; Garcia-Pavia P
    Eur J Heart Fail; 2022 Aug; 24(8):1387-1396. PubMed ID: 35650018
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study.
    Cheung CL; Sing CW; Lau WCY; Li GHY; Lip GYH; Tan KCB; Cheung BMY; Chan EWY; Wong ICK
    Cardiovasc Diabetol; 2021 Mar; 20(1):71. PubMed ID: 33766030
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Augmented intelligence decision tool for stroke prediction combines factors from CHA
    Horne BD; Jacobs V; May HT; Graves KG; Bunch TJ
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1452-1461. PubMed ID: 31115939
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Atrial fibrillation and medication treatment among centenarians: Are all very old patients treated the same?
    Kreutz R; Schmidt IM; Dräger D; Brüggen F; Hörter S; Zwillich C; Kuhlmey A; Gellert P
    Geriatr Gerontol Int; 2018 Dec; 18(12):1634-1640. PubMed ID: 30259631
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hospitalization affects the anticoagulation patterns of patients with atrial fibrillation.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Giamouzis G; Karvounis H; Tzikas A; Giannakoulas G
    J Thromb Thrombolysis; 2019 Aug; 48(2):225-232. PubMed ID: 30830586
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.
    Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M;
    Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evidence-Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation.
    Schaffer AL; Falster MO; Brieger D; Jorm LR; Wilson A; Hay M; Leeb K; Pearson S; Nasis A
    J Am Heart Assoc; 2019 Dec; 8(24):e014287. PubMed ID: 31795822
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
    Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
    Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trends in preadmission oral anticoagulant use and clinical outcome in atrial fibrillation patients admitted with acute stroke in Denmark.
    Larsen LK; Ovesen C; Frost L; Damgaard D; Christensen H; Johnsen SP
    Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):112-120. PubMed ID: 31855254
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF).
    Kim H; Lee YS; Kim TH; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Shim J; Uhm JS; Park HW; Choi EK; Kim JB; Kim C; Kim J; Joung B
    Korean J Intern Med; 2020 Jan; 35(1):99-108. PubMed ID: 31014064
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation.
    Franchi C; Antoniazzi S; Proietti M; Nobili A; Mannucci PM;
    Br J Clin Pharmacol; 2018 Sep; 84(9):2010-2019. PubMed ID: 29745441
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    Europace; 2014 Feb; 16(2):195-201. PubMed ID: 24036378
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Toorop MMA; Chen Q; Tichelaar VYIG; Cannegieter SC; Lijfering WM
    Eur Heart J; 2021 Oct; 42(40):4126-4137. PubMed ID: 34269375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anticoagulation in "real world" patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.
    Volterrani M; Iellamo F; Rosano G; Guarini P; Pusineri E; Bonassi S; Chimini C; Zaccà F; Proto C;
    Int J Cardiol; 2013 Oct; 168(5):4729-33. PubMed ID: 23948115
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry.
    Bassand JP; Virdone S; Camm AJ; Fox KAA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Keltai M; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
    Diabetes Obes Metab; 2023 Oct; 25(10):3040-3053. PubMed ID: 37435777
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis.
    Grymonprez M; Steurbaut S; De Sutter A; Lahousse L
    Open Heart; 2020 Dec; 7(2):. PubMed ID: 33361315
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation.
    Chao TF; Chiang CE; Chan YH; Liao JN; Chen TJ; Lip GYH; Chen SA
    Heart Rhythm; 2021 Jun; 18(6):871-877. PubMed ID: 33640447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.